Financials

  • Market Capitalization 6.06 B
  • Employee 103
  • Founded 2018
  • CEO N/A
  • Website www.erasca.com
  • Headquarter Delaware, United States
  • FIGI BBG00MTSR883
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-17.4
Relación precio/flujo de caja
1 601.5

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1165
XENE
Xenon Pharmaceuticals Inc. - Common Shares
67.30 USD-0.62%+6.69%+28.00%+64.99%6.51 B USD
1177
SRRK
Scholar Rock Holding Corporation - Common Stock
53.78 USD-1.68%-4.39%+17.17%+79.15%6.44 B USD
1221
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
300.97 USD-2.68%-6.50%+17.98%+60.84%6.03 B USD
1250
BLTE
Belite Bio Inc - American Depositary Shares
146.68 USD-0.24%-5.67%+1.17%+132.42%5.77 B USD

Noticias